Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System

Area of Science:

• Nephrology
• Pharmacology
• Physiology

Background:

• Diabetic nephropathy is a leading cause of kidney failure.
• Glomerular hyperfiltration is a hallmark of early diabetic nephropathy.
• Tubular reabsorption modulation impacts kidney function.

Purpose of the Study:

• To review the effects of modulating tubular reabsorption proximal to the macula densa on glomerular filtration rate (GFR).
• To explore the role of tubuloglomerular feedback (TGF) activation by sodium-glucose co-transporter 2 (SGLT2) inhibitors in diabetic nephropathy.
• To consider alternative explanations for the renoprotective effects of SGLT2 inhibitors.

Main Methods:

• Review of existing literature on SGLT2 inhibitors, acetazolamide, and furosemide.
• Analysis of the mechanisms of tubular reabsorption and TGF activation.
• Discussion of physiological bases for renoprotection in diabetic nephropathy.

Main Results:

• SGLT2 inhibitors, acetazolamide, and furosemide decrease sodium reabsorption upstream of the macula densa, increasing TGF activity.
• Sustained TGF activation by SGLT2 inhibitors is possible due to partial adaptation in tubular reabsorption and TGF response.
• SGLT2 inhibitors preserve GFR in early and advanced diabetic nephropathy, but mechanisms in advanced stages are not fully understood.

Conclusions:

• TGF activation partially explains SGLT2 inhibitor efficacy in diabetic nephropathy.
• Alternative mechanisms, including microvascular effects and combination therapies, contribute to renoprotection.
• Further research is needed to elucidate the role of TGF in human diabetic nephropathy and the full benefits of SGLT2 inhibitors.